SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193805-20-000569
Filing Date
2020-05-08
Accepted
2020-05-08 17:22:19
Documents
9

Document Format Files

Seq Description Document Type Size
1 e619613_s3-at.htm S-3 269898
2 e619613_ex3-1.htm EX-3.1 23799
3 e619613_ex3-2.htm EX-3.2 96402
4 e619613_ex4-9.htm EX-4.9 381078
5 e619613_ex5-1.htm EX-5.1 24716
6 e619613_ex23-1.htm EX-23.1 1881
7 GRAPHIC image_001.jpg GRAPHIC 4073
8 GRAPHIC image_002.jpg GRAPHIC 4070
9 GRAPHIC image_003.jpg GRAPHIC 3391
  Complete submission text file 0001193805-20-000569.txt   815086
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-238139 | Film No.: 20861820
SIC: 2834 Pharmaceutical Preparations